PeptideStack
5.2kquestions
20kanswers
220users

My tirzepatide vial sat at minus 80 °C for fourteen days — is testing worth it before use?

Asked 21 Jul 2026Modified 9 days agoViewed 3k times
14

For reference: tirzepatide · minus 80 °C · fourteen days.

I am at the decision point and I would rather think it through than improvise.

I would rather spend money on measurement than on redundancy.

How do I make this decision on evidence rather than on feel?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questionspeptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questionstirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
TH
askedtyndall_haze38k3821 Jul 2026
Worth saying whether the vial has been opened, because that starts a different clock. – bac_or_bust 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 3k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.